PBM

All articles by PBM

Dermavant’s Todd Zavodnick is moving derm into the digital world
Dermavant’s Todd Zavodnick is moving derm into the digital world
MM+M Staff
February 21, 2024
1:16 pm

Immuno-dermatology needs to move to the digital era, Dermavant CEO Todd Zavodnick tells Jack O’Brien. Plus, policy updates and our Trends segment.

PBM trade group pushes back on House bill targeting spread pricing
PBM trade group pushes back on House bill targeting spread pricing
Lecia Bushak
February 20, 2024
3:11 pm

The House Committee on Oversight and Accountability recently voted to advance another PBM reform bill in Congress. Here’s how the PBM industry responded.

Pharma has little visibility into the growing area of PBM fees
Pharma has little visibility into the growing area of PBM fees
Marc Iskowitz
December 11, 2023
8:00 am

Lack of consistent insight into PBM service fees puts drugmakers at a disadvantage when calculating prices.

Biden administration’s limit on drug industry middlemen backfires, pharmacists say
Biden administration’s limit on drug industry middlemen backfires, pharmacists say
Arthur Allen, KFF Health News
November 16, 2023
7:00 am

The so-called PBMs have long clawed back a fee from pharmacies weeks or months after they dispense a drug.

Senate panel passes PBM, mental health reform package
Senate panel passes PBM, mental health reform package
Lecia Bushak
November 9, 2023
1:40 pm

The Better Mental Health Care, Lower-Cost Drugs, and Extenders Act would boost mental health services as well as target PBMs and their role in high drug prices.

  • From Our Partners